U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07886541) titled 'VATS or Intrapleural Enzymatic Therapy for Patients With Empyema.' on Sept. 25.

Brief Summary: A parapneumonic pleural infection is a frequently encountered and serious medical emergency with high morbidity and mortality in specific patient groups (especially in the elderly and immunocompromised). The burden of disease is high; extensive hospital stays, reduced Health-Related Quality of Life (HR-QoL) and long times to return to daily activities or to work are reported by patients and in studies. Standard care of pleural infections consists of placement of a chest tube and antibiotics. It is estimated that approximately 50% of patien...